[Can the survival of patients with recurrent disease after curative resection of colorectal cancer be prolonged by the administration of cimetidine?].
Administration of cimetidine after curative surgery can improve prognosis of patients with colorectal cancer. In this study, we analyzed whether cimetidine can influence the survival of patients with a recurrent disease after colorectal surgery. The subjects were 29 patients with recurrent disease: 14 patients were administered with cimetidine and 15 patients were not. In the cimetidine administered group, seven cases were recurrent in the liver, 5 cases in a local site and 1 case in the lymph node, whereas 7 cases were recurrent in the liver, 4 cases in a local site and 3 cases in the lung for the non-cimetidine administered group. There were no significant differences for both groups in terms of patient's survival after recurrence. Although it was not significant, the patient's survival after curative resection of recurrent disease for the cimetidine administered group was better than the non cimetidine administered group. Although the results did not show cimetidine could influence the overall survival of the patients after recurrence, it might be possible to improve the survival of the patients after resection of the recurrent disease.
Yoshimatsu
Kazuhiko
K
Dept. of Surgery, Tokyo Women's Medical University Medical Center East.
Ishibashi
Keiichiro
K
Yokomizo
Hajime
H
Umehara
Arihiro
A
Yoshida
Kiyohito
K
Fujimoto
Takashi
T
Watanabe
Kiyo
K
Otani
Taisuke
T
Matsumoto
Atsuo
A
Osawa
Gakuji
G
Ogawa
Kenji
K
D002927:Cimetidine / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000401:mortality* / Q000601:surgery*; D006801:Humans; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D011379:Prognosis
D002927:Cimetidine